Conolidine’s analgesic effects stem from its interaction with non-opioid pain pathways. Unlike opioids, which bind to µ-opioid receptors inside the central nervous procedure, conolidine modulates alternate molecular targets. A Science Advances review found that conolidine interacts While using the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide availability. By https://johnathanwqnvt.luwebs.com/39602945/conolidin-to-replace-traditional-painkillers-fundamentals-explained